Routine administration of the Dengvaxia dengue vaccine in low-transmission areas could increase the number of patients hospitalized with severe secondary infections, according to study data, and led the researchers to recommend patients undergo serological testing before vaccination.
This activity is supported by an educational grant from AbbVie and Merck & Co., Inc.
Discoveries from ASM Microbe: HIV
Get the best of the journals.Read abstracts, search and filter results, gain perspective, view graphics.
This activity is supported by an educational grant from Merck & Co., Inc.
Click here for related story
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2016 All Rights Reserved.